Beutel, Goodman & Co Ltd.
- SEC CIK
- 0001361974
- Latest filing
- Aug 12, 2026
NVS holding history
Novartis AG in every 13F filed by Beutel, Goodman & Co Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 18,599
- Value
- $2.91M
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 18,599 | $2.91M | <0.1% | −225−1.2% | Reduced | Holders |
| Q1 2026 | 18,824 | $2.88M | <0.1% | +169+0.9% | Added | Holders |
| Q4 2025 | 18,655 | $2.57M | <0.1% | +215+1.2% | Added | Holders |
| Q3 2025 | 18,440 | $2.36M | <0.1% | +6,330+52.3% | Added | Holders |
| Q2 2025 | 12,110 | $1.47M | <0.1% | −1,610−11.7% | Reduced | Holders |
| Q1 2025 | 13,720 | $1.53M | <0.1% | +11,045+412.9% | Added | Holders |
| Q4 2024 | 2,675 | $260.0K | <0.1% | −250−8.5% | Reduced | Holders |
| Q3 2024 | 2,925 | $336.0K | <0.1% | −1,480−33.6% | Reduced | Holders |
| Q2 2024 | 4,405 | $468.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 4,405 | $426.0K | <0.1% | +40+0.9% | Added | Holders |
| Q4 2023 | 4,365 | $440.0K | <0.1% | +1,530+54.0% | Added | Holders |
| Q3 2023 | 2,835 | $288.0K | <0.1% | +225+8.6% | Added | Holders |
| Q2 2023 | 2,610 | $263.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,610 | $240.0K | <0.1% | +120+4.8% | Added | Holders |
| Q4 2022 | 2,490 | $225.0K | <0.1% | +2,490 | New | Holders |